Concomitant disease should be considered when treating progressive glaucoma
Click Here to Manage Email Alerts
WAIKOLOA, Hawaii — Ophthalmologists should consider co-management of other diseases when treating progressive glaucoma, according to a speaker here.
“I think that we need to remind ourselves, even as we rush through clinic, to think about the linkage to common disease that puts the optic nerve at risk,” Jeffrey L. Goldberg, MD, PhD, said at Hawaiian Eye 2022.
To aid with co-management, he said, physicians should ensure the patient’s hypertension is under control, have patients avoid hypotensive medications at bedtime and encourage the use of a continuous positive airway pressure machine in patients with obstructive sleep apnea. Patients should also be treated for inflammatory disorders, and metabolic and nutritional status should be optimized. In young patients with unilateral glaucoma, MRI and neuroimaging should be considered.
Goldberg said ophthalmologists should work with the patient’s other doctors to help manage their concomitant diseases.
“Let’s welcome a future where we test for and treat these pathologies, and I think we have a number of different candidate therapies coming down the road in that direction right now,” he said.